A Mouse Model for Human Osteogenesis Imperfecta Type VI

被引:44
|
作者
Bogan, Rosalind [1 ]
Riddle, Ryan C. [1 ,2 ]
Li, Zhu [1 ]
Kumar, Sarvesh [1 ]
Nandal, Anjali [1 ]
Faugere, Marie-Claude [3 ]
Boskey, Adele [4 ]
Crawford, Susan E. [5 ]
Clemens, Thomas L. [1 ,2 ]
机构
[1] Johns Hopkins Univ, Dept Orthopaed Surg, Sch Med, Baltimore, MD 21287 USA
[2] Baltimore Vet Adm Med Ctr, Baltimore, MD USA
[3] Univ Kentucky, Dept Med, Lexington, KY 40506 USA
[4] Hosp Special Surg, Mineralized Tissue Res Lab, New York, NY 10021 USA
[5] St Louis Univ, Dept Pathol, St Louis, MO 63103 USA
关键词
PEDF; OSTEOGENESIS IMPERFECTA; BONE MINERALIZATION; OSTEOBLAST; EPITHELIUM-DERIVED FACTOR; BONE HISTOMORPHOMETRY; PEDF; MUTATIONS; RECEPTOR; NOMENCLATURE; DEFICIENCY; SERPINF1; COLLAGEN; SYMBOLS;
D O I
10.1002/jbmr.1892
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Osteogenesis imperfecta type VI (OI type VI) has recently be linked to a mutation in the SERPINF1 gene, which encodes pigment epithelium-derived factor (PEDF), a ubiquitously expressed protein originally described for its neurotrophic and antiangiogenic properties. In this study, we characterized the skeletal phenotype of a mouse with targeted disruption of Pedf. In normal mouse bone, Pedf was localized to osteoblasts and osteocytes. Micro-computed tomography (mu CT) and quantitative bone histomorphometry in femurs of mature Pedf null mutants revealed reduced trabecular bone volume and the accumulation of unmineralized bone matrix. Fourier transform infrared microscopy (FTIR) indicated an increased mineral:matrix ratio in mutant bones, which were more brittle than controls. In vitro, osteoblasts from Pedf null mice exhibited enhanced mineral deposition as assessed by Alizarin Red staining and an increased mineral:matrix determined by FTIR analysis of calcified nodules. The findings in this mouse model mimic the principal structural and biochemical features of bone observed in humans with OI type VI and consequently provide a useful model with which to further investigate the role of PEDF in this bone disorder.
引用
收藏
页码:1531 / 1536
页数:6
相关论文
共 50 条
  • [41] Unique micro- and nano-scale mineralization pattern of human osteogenesis imperfecta type VI bone
    Fratzl-Zelman, Nadja
    Schmidt, Ingo
    Roschger, Paul
    Roschger, Andreas
    Glorieux, Francis H.
    Klaushofer, Klaus
    Wagermaier, Wolfgang
    Rauch, Frank
    Fratzl, Peter
    BONE, 2015, 73 : 233 - 241
  • [42] Osteogenesis Imperfecta Type IIA
    Mittal, Aliza
    Sureka, Binit
    Bansal, Neha
    Chellani, Harish
    JOURNAL OF CLINICAL NEONATOLOGY, 2015, 4 (01) : 60 - 61
  • [43] A NEW TYPE OF OSTEOGENESIS IMPERFECTA
    CRAWFURD, MD
    WINTER, RM
    JOURNAL OF MEDICAL GENETICS, 1982, 19 (02) : 158 - 158
  • [44] Osteogenesis imperfecta type V
    Hui, Peter Kei Tat
    Tung, Joanna Y. L.
    Lam, Wendy W. M.
    Chau, M. T.
    SKELETAL RADIOLOGY, 2011, 40 (12) : 1633 - 1633
  • [45] New Ifitm5 S42L mouse model for atypical type VI Osteogenesis Imperfecta recapitulates patient phenotype.
    Ram, Gali Guterman
    Hedjazi, Ghazal
    Stephan, Chris
    Blouin, Stephane
    Schemenz, Victoria
    Wagermaier, Wolfgang
    Zwerina, Jochen
    Fratzl, Peter
    Kozloff, Kenneth M.
    Fratzl-Zelman, Nadja
    Marini, Joan C.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2020, 35 : 299 - 299
  • [46] Bone tissue characterization of a mouse model of atypical type VI osteogenesis imperfecta reveals hypermineralization of the bone matrix, elevated osteocyte lacunardensity and altered vascularity
    Hedjazi, Ghazal
    Guterman-Ram, Gali
    Blouin, Stephane
    Roschger, Paul
    Klaushofer, Klaus
    Fratzl-Zelman, Nadja
    Marini, Joan C.
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 37 - 37
  • [47] Osteogenesis imperfecta [Osteogenesis imperfecta]
    Salzmann M.
    Krohn C.
    Berger N.
    Der Orthopäde, 2014, 43 (8): : 764 - 771
  • [48] Alendronate treatment for infants with osteogenesis imperfecta: Demonstration of efficacy in a mouse model
    McCarthy E.A.
    Raggio C.L.
    Hossack M.D.
    Miller E.A.
    Jain S.
    Boskey A.L.
    Camacho N.P.
    Pediatric Research, 2002, 52 (5) : 660 - 670
  • [49] A Controlled Study of the Effects of Alendronate in a Growing Mouse Model of Osteogenesis Imperfecta
    N.P. Camacho
    C.L. Raggio
    S.B. Doty
    L. Root
    V. Zraick
    W.A. Ilg
    T.R. Toledano
    A.L. Boskey
    Calcified Tissue International, 2001, 69 : 94 - 101
  • [50] Mechanisms Underlying Increased Osteoclastogenesis in the Mouse Model of Osteogenesis Imperfecta Due to Mutation in Collagen Type I
    Boraschi, Iris
    Niemi, Erene C.
    Rauch, Frank
    Nakamura, Mary
    Komarova, Svetlana
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 : 123 - 123